Succinic Acid

Succinic Acid

SCHEMBL93822

C=C.N.N.O=C(O)CCC(=O)O.O=C(O)CCC(=O)O

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4

The experimentally established mechanism targets of Succinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.75
EGLN1 Q9GZT9 4/20 0.75
ALKBH5 Q6P6C2 1/20 0.75
SUCNR1 Q9BXA5 1/20 0.75
SLC22A6 Q4U2R8 1/20 0.53
SLC15A2 Q16348 1/20 0.53
MAPK1 P28482 1/20 0.53
SLC13A3 Q8WWT9 1/20 0.53
OR51E2 Q9H255 1/20 0.53
TSHR P16473 2/20 0.50
NFKB1 P19838 1/20 0.50
PMP22 Q01453 1/20 0.50
KDM4E B2RXH2 3/20 0.47
KDM5C P41229 3/20 0.47
PHF8 Q9UPP1 3/20 0.47
KDM2A Q9Y2K7 3/20 0.47
KDM6B O15054 2/20 0.47
FOLH1 Q04609 1/20 0.47
GABRR1 P24046 1/20 0.47
FFAR3 O14843 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinic Acid SCHEMBL518643 1.00 LMNA (0.75) LMNAEGLN1ALKBH5SUCNR1SLC22A6
Succinic Acid SCHEMBL468618 0.96 LMNA (0.69) LMNAEGLN1ALKBH5SUCNR1SLC22A6
Succinic Acid SCHEMBL2572722 0.96 LMNA (0.69) LMNAEGLN1ALKBH5SUCNR1SLC22A6
Succinic Acid SCHEMBL21219028 0.96 LMNA (0.69) LMNAEGLN1ALKBH5SUCNR1SLC22A6
Succinic Acid SCHEMBL468678 0.96 LMNA (0.69) LMNAEGLN1ALKBH5SUCNR1SLC22A6
Succinic Acid SCHEMBL468649 0.96 LMNA (0.69) LMNAEGLN1ALKBH5SUCNR1SLC22A6
Succinic Acid SCHEMBL468630 0.96 LMNA (0.69) LMNAEGLN1ALKBH5SUCNR1SLC22A6
Succinic Acid SCHEMBL17077298 0.96 LMNA (0.69) LMNAEGLN1ALKBH5SUCNR1SLC22A6
Succinic Acid SCHEMBL295052 0.96 LMNA (0.82) LMNAEGLN1ALKBH5SUCNR1SLC22A6
Succinic Acid SCHEMBL468680 0.96 LMNA (0.82) LMNAEGLN1ALKBH5SUCNR1SLC22A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1418 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260076893-A1 SELF-FOAMING CLEANSING COMPOSITION CONOPCO, INC., D/B/A UNILEVER (US) 2026-03-19 US claimed
EP-4586992-A2 SELF-FOAMING CLEANSING COMPOSITION Unilever IP Holdings B.V. (NL) 2025-07-23 EP claimed
EP-4586994-A1 SELF-FOAMING CLEANSING COMPOSITION Unilever IP Holdings B.V. (NL) 2025-07-23 EP claimed
US-20250222110-A1 METHODS AND COMPOSITIONS FOR TREATMENT OF AGE-RELATED CATARACTS LIVIONEX INC (US) 2025-07-10 US claimed
US-20250049662-A1 AQUEOUS COSMETIC COMPOSITION COMPRISING VANILLIN OR ONE OF ITS DERIVATIVES, A SPECIFIC SEQUESTERING AGENT, AND POSSIBLY AT LEAST ONE ADDITIONAL ANTIMICROBIAL L'OREAL (FR) 2025-02-13 US claimed
EP-4216911-B1 MOISTURIZING ANTIBACTERIAL COMPOSITION UNILEVER IP HOLDINGS B V (NL) 2025-01-22 EP claimed
US-20240382597-A1 FORMULATIONS OF ANTI-INFLAMMATORY AGENTS COMPRISING MSM WITH ENHANCED SOLUBILITY IN WATER LIVIONEX INC (US) 2024-11-21 US claimed
EP-4451876-A1 AQUEOUS COSMETIC COMPOSITION COMPRISING VANILLIN OR ONE OF ITS DERIVATIVES, A SPECIFIC SEQUESTERING AGENT, AND POSSIBLY AT LEAST ONE ADDITIONAL ANTIMICROBIAL L'OREAL (FR) 2024-10-30 EP claimed
US-20240299279-A1 TRANSPARENT COSMETIC COMPOSITION WITH ASCORBIC ACID AND A SPECIFIC CATIONIC POLYMER L'OREAL (FR) 2024-09-12 US claimed
WO-2024133219-A1 TRANSPARENT COSMETIC COMPOSITION WITH ASCORBIC ACID, A SPECIFIC CATIONIC POLYMER, AND AT LEAST ONE POLYOXYLENATED ALKYLETHER DIMETHYLSILANE COMPOUND L'OREAL (FR) 2024-06-27 WO claimed
US-5738914-A EXPOSING THE SUBSTRATE WITH COPPER SULFATE COMPRISING ETHYLENE DIAMINE DISUCCINIC ACID BIODEGRADABLE CHELATE FOR METAL ION TO PREVENT OR REDUCE METAL HYDROXIDE PRECIPITES FORMING THE ASSOCIATED OCTEL COMPANY LIMITED (GB) 1998-04-14 US claimed
WO-1998000514-A1 NONAQUEOUS, PARTICULATE-CONTAINING LIQUID DETERGENT COMPOSITIONS WITH SURFACTANT-STRUCTURED LIQUID PHASE THE PROCTER & GAMBLE COMPANY (US) 1998-01-08 WO claimed
WO-1998000516-A1 PREPARATION OF NON-AQUEOUS, PARTICULATE-CONTAINING LIQUID DETERGENT COMPOSITIONS WITH SURFACTANT-STRUCTURED LIQUID PHASE THE PROCTER & GAMBLE COMPANY (US) 1998-01-08 WO claimed
EP-0784669-A1 PROCESS FOR PREPARING NON-AQUEOUS, BLEACH-CONTAINING LIQUID DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-07-23 EP claimed
EP-0783563-A1 NONAQUEOUS BLEACH-CONTAINING LIQUID DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-07-16 EP claimed
WO-1997000938-A1 NONAQUEOUS, PARTICULATE-CONTAINING LIQUID DETERGENT COMPOSITIONS WITH ALKYL BENZENE SULFONATE SURFACTANT THE PROCTER & GAMBLE COMPANY (US) 1997-01-09 WO claimed
WO-1996033254-A1 NONAQUEOUS, PARTICULATE-CONTAINING LIQUID DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1996-10-24 WO claimed
EP-0738778-A1 Nonaqueous, particulate-containing liquid detergent compositions THE PROCTER & GAMBLE COMPANY (US) 1996-10-23 EP claimed
WO-1996010072-A1 PROCESS FOR PREPARING NON-AQUEOUS, BLEACH-CONTAINING LIQUID DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1996-04-04 WO claimed
WO-1996010073-A1 NONAQUEOUS BLEACH-CONTAINING LIQUID DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1996-04-04 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250222110-A1 METHODS AND COMPOSITIONS FOR TREATMENT OF AGE-RELATED CATARACTS MSMO1, SLC16A8, SMS LMNA 3443/4885EGLN1 1594/4885ALKBH5 1503/4885
US-20250049662-A1 AQUEOUS COSMETIC COMPOSITION COMPRISING VANILLIN OR ONE OF ITS DERIVATIVES, A SPECIFIC SEQUESTERING AGENT, AND POSSIBLY AT LEAST ONE ADDITIONAL ANTIMICROBIAL C1S, VDAC1, DSG1 LMNA 1593/4885EGLN1 1762/4885ALKBH5 1176/4885
US-20240382597-A1 FORMULATIONS OF ANTI-INFLAMMATORY AGENTS COMPRISING MSM WITH ENHANCED SOLUBILITY IN WATER TNF, CD14, CXCL8 LMNA 2944/4885EGLN1 4730/4885ALKBH5 2463/4885
US-20240299279-A1 TRANSPARENT COSMETIC COMPOSITION WITH ASCORBIC ACID AND A SPECIFIC CATIONIC POLYMER GALC, COLGALT1, PROC LMNA 221/4885EGLN1 2246/4885ALKBH5 1979/4885
US-20260076893-A1 SELF-FOAMING CLEANSING COMPOSITION FASN, LSS, LIPA LMNA 584/4885EGLN1 1119/4885ALKBH5 316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.